Premium Nahrungsergänzungsmittel | artgerecht

Cytotoxicity – Definition, Types and Medical Role

Cytotoxicity refers to the ability of certain substances or cells to damage or destroy other cells. It plays a key role in oncology, immunology, and pharmaceutical research.

Regular tips about health Regular tips about health

Things worth knowing about "Cytotoxicity"

Cytotoxicity refers to the ability of certain substances or cells to damage or destroy other cells. It plays a key role in oncology, immunology, and pharmaceutical research.

What is Cytotoxicity?

Cytotoxicity describes the property of a substance, organism, or cell to damage, impair, or destroy other cells. The term derives from the Greek kytos (cell) and Latin toxicus (poisonous). Cytotoxic effects can be used therapeutically – for example in cancer treatment – or can occur as unwanted side effects of drugs, chemicals, or environmental toxins.

Types of Cytotoxicity

Direct Cytotoxicity

Direct cytotoxicity occurs when a substance acts immediately on a cell, disrupting essential functions such as cellular respiration, DNA replication, or membrane integrity. Common causes include chemotherapeutic agents, heavy metals, and reactive oxygen species.

Immune-Mediated Cytotoxicity

The immune system can selectively destroy cells through a process called cell-mediated cytotoxicity. Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells play a central role by recognizing infected or malignant cells and inducing their programmed cell death (apoptosis).

Antibody-Dependent Cellular Cytotoxicity (ADCC)

In antibody-dependent cellular cytotoxicity, antibodies label target cells, prompting immune cells – primarily NK cells – to destroy them. This mechanism is also harnessed by therapeutic monoclonal antibodies used in cancer immunotherapy.

Medical Significance

Oncology

In cancer therapy, cytotoxicity is deliberately exploited to destroy tumor cells. Cytostatic drugs (cytotoxic agents) inhibit cancer cell growth or kill them directly. Major drug classes include alkylating agents, antimetabolites, topoisomerase inhibitors, and taxanes. Because these agents are not fully selective for cancer cells, side effects such as hair loss, nausea, and immunosuppression are common.

Immunology and Transplantation Medicine

Cytotoxic reactions are also relevant in organ rejection and autoimmune diseases. The immune system of a transplant recipient may recognize transplanted cells as foreign and mount a cytotoxic response. Immunosuppressive drugs are used to prevent such unwanted cytotoxicity.

Toxicology and Drug Development

During drug development, the cytotoxicity of new compounds is systematically evaluated to ensure that active substances do not cause harmful effects on healthy cells. Standardized in vitro cytotoxicity assays – such as the MTT assay or the LDH release assay – are used to assess cellular tolerability.

Measurement and Testing Methods

Cytotoxicity is measured in laboratory and research settings using a variety of methods:

MTT Assay: Measures the metabolic activity of living cells through the reduction of a colorimetric dye.
LDH Release Assay: Quantifies lactate dehydrogenase released from damaged cells as a marker of cytotoxicity.
Trypan Blue Exclusion Test: Living cells exclude the dye, while dead cells stain blue.
Annexin V Staining / Flow Cytometry: Distinguishes between apoptotic and necrotic cells.

Cytotoxicity and Apoptosis

Cytotoxic effects frequently lead to apoptosis – the programmed, orderly death of a cell. Unlike necrosis, in which cells die chaotically and trigger inflammatory responses, apoptosis proceeds in a controlled manner with minimal tissue damage. Many chemotherapeutic agents and immune cells deliberately engage the apoptotic pathway to eliminate tumor cells.

References

Lodish H. et al. - Molecular Cell Biology, 8th Edition. W.H. Freeman and Company, 2016.
Abbas AK, Lichtman AH, Pillai S. - Cellular and Molecular Immunology, 10th Edition. Elsevier, 2021.
European Medicines Agency (EMA) - Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products. EMA/CHMP/SWP/28367/07 Rev. 1, 2017. Available at: https://www.ema.europa.eu

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category